Table 5 Event-free survival EFS and overall survival OS of stage III subtypes
From: Localized Wilms’ tumor in low-middle-income countries (LMIC): how can we get better?
No. | No. of events | 5-year EFS (%) | p value | No of deaths | 5-year OS (%) | p value | |
|---|---|---|---|---|---|---|---|
Whole group | 46 | 7 | 84.8% | 5 | 89.1% | ||
Lymph node | |||||||
Negative | 39 | 6 | 84.6% | 5 | 87.2% | ||
Positive | 7 | 1 | 85.7% | 0.898 | 0 | 100% | 0.285 |
Gross residual | |||||||
No | 44 | 5 | 88.6% | 4 | 90.9% | ||
Yes | 2 | 2 | 0% | * | 1 | 50% | * |
Surgical margin | |||||||
Negative | 42 | 7 | 83.3% | 5 | 88.1% | ||
Positive | 4 | 0 | 100% | * | 0 | 100% | * |
Spillage | |||||||
No | 37 | 5 | 86.5% | 3 | 91.9% | ||
Yes | 9 | 2 | 77.7% | 0.538 | 2 | 77.8% | 0.271 |
IVC infiltration | |||||||
No | 43 | 7 | 83.7% | 5 | 88.4% | ||
Yes | 3 | 0 | 100% | * | 0 | 100% | * |
Number of factors to be considered stage III | |||||||
0–2 factors | 40 | 7 | 82.5% | 5 | 87.5% | ||
> = 3 factors | 6 | 0 | 100% | 0.291 | 0 | 100% | 0.364 |
Timing to start radiotherapy | |||||||
2 weeks | 22 | 2 | 90.9% | 2 | 90.9% | ||
= > 2 weeks | 17 | 3 | 82.4% | 0.398 | 2 | 88.2% | 0.692 |
= < 1 month | 31 | 3 | 90.3% | 2 | 93.5% | ||
> 1 month | 8 | 2 | 75.0% | 0.198 | 2 | 75.0% | 0.148 |